| NSC | Drug name | FDA status | Mechanism of action | PubChem SID |
| 740 | Methotrexate | FDA approved | Df|DHFR | 126941 |
| 750 | Busulfan | FDA approved | A7|AlkAg | - |
| 752 | 6-Thioguanine | FDA approved | Ds|IMPDH2|IMPDH | - |
| 755 | 6-Mercaptopurine | FDA approved | Ds|PPAT | - |
| 762 | Nitrogen mustard | FDA approved | A7|AlkAg | - |
| 1390 | Allopurinol | FDA approved | AM|XDH | - |
| 3053 | Actinomycin D | FDA approved | Db | - |
| 3088 | Chlorambucil | FDA approved | A7|AlkAg | - |
| 6396 | Thiotepa | FDA approved | A7|AlkAg | - |
| 8806 | Melphalan | FDA approved | A7|AlkAg | - |
| 9706 | Triethylenemelamine | FDA approved | A7|AlkAg | 5799 |
| 13875 | Altretamine | FDA approved | Db|AlkAg | - |
| 14229 | Acrichine | FDA approved | Db|AP | - |
| 18509 | Aminolevulinic acid | FDA approved | AM | - |
| 19893 | Fluorouracil | FDA approved | Ds|Rs|TYMS | - |
| 24559 | Mithramycin | FDA approved | Db|Rs | - |
| 25154 | Pipobroman | FDA approved | A7|AlkAg | - |
| 26271 | Cyclophosphamide | FDA approved | A7|AlkAg | - |
| 26980 | Mitomycin | FDA approved | A2|AlkAg | 5746 |
| 27640 | Floxuridine | FDA approved | Ds|TYMS | - |
| 32065 | Hydroxyurea | FDA approved | AM|Dr | - |
| 34462 | Uracil Mustard | FDA approved | A7|AlkAg | 6194 |
| 36405 | Chelerythrine | Clinical trial | BCL2|PK:PRKCA,STK | 72311 |
| 38721 | Mitotane | FDA approved | A7|Ho|AlkAg|anti-Ho|CYP11A1 | - |
| 45388 | Dacarbazine | FDA approved | A7|AlkAg | - |
| 45923 | Methoxsalen | FDA approved | Db | - |
| 49842 | Vinblastine | FDA approved | TUBB|Tu-frag | - |
| 62343 | 3-Bromopyruvate (acid) | Clinical trial | Mito|HK2 | - |
| 63878 | Cytarabine | FDA approved | Ds | - |
| 66847 | Thalidomide | FDA approved | Ang|Immunomodulatory | - |
| 67574 | Vincristine | FDA approved | TUBB|Tu-frag | 249332 |
| 71423 | Megestrol Acetate | FDA approved | Ho|PGR | 11683 |
| 75520 | tfdu | FDA approved | TYMS | - |
| 77213 | Procarbazine | FDA approved | A7|AlkAg | 9703 |
| 79037 | Lomustine | FDA approved | A6|AlkAg | - |
| 82151 | Daunorubicin | FDA approved | TOP2 | - |
| 85998 | Streptozocin | FDA approved | A7|AlkAg | - |
| 92859 | Arsenic trioxide | FDA approved | Apo | 261004 |
| 102816 | Azacitidine | FDA approved | DNMT | - |
| 105014 | Cladribine | FDA approved | Ds|ADA | - |
| 109724 | Ifosfamide | FDA approved | A7|AlkAg | - |
| 118218 | Fludarabine | FDA approved | Ds|AM|Dr|STAT1 | - |
| 119875 | Cisplatin | FDA approved | A7|AlkAg | - |
| 122758 | Isotretinoin | FDA approved | Ho|RXR|Differentiator | - |
| 122819 | Teniposide | FDA approved | TOP2 | - |
| 123127 | Doxorubicin | FDA approved | TOP2 | - |
| 125066 | Bleomycin | FDA approved | Db | - |
| 125973 | Paclitaxel | FDA approved | TUBB|Tu-stab | - |
| 127716 | Decitabine | FDA approved | AM|DNMT | - |
| 130181 | Tirapazamine | Clinical trial | DDI | - |
| 138783 | Bendamustine | FDA approved | A2|A6|AlkAg | 77082 |
| 141540 | Etoposide | FDA approved | TOP2 | - |
| 142784 | Tempol | Clinical trial | RP|FRS | - |
| 169780 | Dexrazoxane | FDA approved | TOP2|NonCan:Cardioprotective | - |
| 180973 | Tamoxifen | FDA approved | Ho|SERM | - |
| 218321 | Pentostatin | FDA approved | Ds|AM|ADA | - |
| 221019 | Wortmannin | Clinical trial | PK:PIK3 | 312145 |
| 226080 | Rapamycin | FDA approved | PK:STK,MTOR | - |
| 241240 | Carboplatin | FDA approved | A7|AlkAg | - |
| 246131 | Valrubicin | FDA approved | TOP2 | - |
| 256439 | Idarubicin | FDA approved | TOP2 | - |
| 256942 | Epirubicin | FDA approved | TOP2 | - |
| 266046 | Oxaliplatin | FDA approved | A7|AlkAg | - |
| 279836 | Mitoxantrone | FDA approved | TOP2 | 4212 |
| 296961 | Amifostine | FDA approved | RP | - |
| 312887 | Fludarabine | FDA approved | Ds|AM|Dr|STAT1 | - |
| 330507 | Tanespimycin | Clinical trial | HSP90 | - |
| 350625 | tic10 | Clinical trial | - | - |
| 362856 | Temozolomide | FDA approved | A7|AlkAg | - |
| 369100 | Imiquimod | FDA approved | AM|TLR7|ImmuneResMod | - |
| 409962 | Carmustine | FDA approved | A7|AlkAg | - |
| 606869 | Clofarabine | FDA approved | Ds | 354624 |
| 608210 | Vinorelbine | FDA approved | TUBB|Tu-frag | 25136944 |
| 609699 | Topotecan | FDA approved | TOP1 | - |
| 613327 | Gemcitabine | FDA approved | Ds | 60750 |
| 616348 | Irinotecan | FDA approved | TOP1 | - |
| 628503 | Docetaxel | FDA approved | TUBB|Tu-stab | 148124 |
| 637037 | O-6-Benzylguanine | Clinical trial | DDR|MGMT | 4578 |
| 639186 | Raltitrexed | FDA approved | Ds|DHFR|TYMS | 135400182 |
| 639966 | Perifosine | Clinical trial | PK:STK,AKT,AKT1,AKT2,AKT3 | 148177 |
| 649890 | Alvocidib | Clinical trial | CCNT1|PK:STK,CDK,CDK1,CDK2,CDK4,CDK6,CDK7,CDK8,CDK9 | - |
| 673596 | 7-Ethyl-10-hydroxycamptothecin | FDA approved | TOP1 | 104842 |
| 678515 | FAU | Clinical trial | Db | - |
| 679828 | PD-98059 | Clinical trial | PK:STK,MAP2K,MAP2K1,MAP2K2 | - |
| 683863 | Irofulven | FDA approved | Apo|AlkAg|RDI | 148189 |
| 683864 | Temsirolimus | FDA approved | PK:STK,MTOR | - |
| 686288 | Aminoflavone | Clinical trial | Db|DDI | 389710 |
| 698215 | XK-469 | Clinical trial | TOP2 | 3246729 |
| 701554 | Seliciclib | Clinical trial | PK:STK,CDK,CDK2,CDK7,CDK9 | 160355 |
| 701852 | Vorinostat | FDA approved | HDAC | - |
| 702294 | Estramustine | FDA approved | A7|TUBB|AlkAg | 54611422 |
| 703081 | SL-0101 | Clinical trial | RPS6 | 14825856 |
| 707545 | Alvespimycin | Clinical trial | HSP90 | - |
| 710464 | AFP464 | Clinical trial | Db|DDI | 399587 |
| 712807 | Capecitabine | FDA approved | Ds|TYMS | 400633 |
| 713563 | Exemestane | FDA approved | Ho|CYP19A1 | 60198 |
| 715055 | Gefitinib | FDA approved | PK:YK,EGFR | - |
| 718781 | Erlotinib | FDA approved | PK:YK,EGFR | - |
| 719276 | Fulvestrant | FDA approved | AM|Ho|ESR|SERM | 104741 |
| 719344 | Anastrozole | FDA approved | Ho|CYP19A1 | - |
| 719345 | Letrozole | FDA approved | Ho|CYP19A1 | - |
| 719627 | Celecoxib | FDA approved | AM|PTGS2|COX2|NonCan:NSAID | - |
| 721517 | Zoledronate | FDA approved | AM|NonCan:Anti-bone resorp | 68740 |
| 721782 | D-1MT | Clinical trial | AM|INDO|IDO1|PK:ROS1 | 405012 |
| 722134 | Sonolisib | Clinical trial | PK:PIK3 | - |
| 727859 | (R)-(-)-Gossypol acetic acid | Clinical trial | Apo|BCL2 | 24203396 |
| 732517 | Dasatinib | FDA approved | BCR-ABL|PK:YK,PDGFR,KIT | - |
| 733504 | Everolimus | FDA approved | PK:STK,MTOR | - |
| 737754 | Pazopanib | FDA approved | PK:YK,PDGFR,FGFR,KIT,VEGFR | 11525740 |
| 741078 | Selumetinib | FDA approved | PK:STK,YK,MAP2K,MAP2K1,MAP2K2 | 10127622 |
| 741899 | BML-277 | Clinical trial | PK:CHEK,CHEK2 | 9969021 |
| 743414 | Imatinib | FDA approved | BCR-ABL|PK:YK | - |
| 745750 | Lapatinib | FDA approved | PK:STK,YK,MET,EGFR,ERBB2,KIT,RAF,VEGFR | 208908 |
| 747599 | Nilotinib | FDA approved | BCR-ABL|PK:YK | 644241 |
| 747971 | Sorafenib | FDA approved | PK:YK,PDGFR,BRAF,KIT,VEGFR,Multikinase | 216239 |
| 747972 | Lenalidomide | FDA approved | FT|Immunomodulatory | 216326 |
| 747973 | Ixabepilone | FDA approved | TUBB|Tu-stab | 6445540 |
| 747974 | Raloxifene | FDA approved | Ho|SERM | 5035 |
| 749226 | Abiraterone | FDA approved | Ho|CYP17A1 | 132971 |
| 750690 | Sunitinib | FDA approved | PK:YK,PDGFR,KIT,VEGFR,Multikinase | 5329102 |
| 750691 | Afatinib | FDA approved | PK:YK,EGFR | 10184653 |
| 751249 | Dactolisib | Clinical trial | PK:STK,PIK3,MTOR | 11977753 |
| 751297 | Y-27632 | Clinical trial | RHO | - |
| 752493 | Iniparib | Clinical trial | PARP|PARP1|PARP2 | - |
| 752840 | Veliparib | Clinical trial | PARP|PARP1|PARP2 | - |
| 753686 | Olaparib | FDA approved | PARP|PARP1 | - |
| 754143 | Depsipeptide | FDA approved | HDAC | 5352062 |
| 754230 | Pralatrexate | FDA approved | Df|CTNNB1|DHFR | 148121 |
| 754344 | Rigosertib | Clinical trial | RAS|Tu-stab|PK:STK,PLK1 | - |
| 754345 | JNJ-28312141 | Clinical trial | PK:YK,CSF1R | - |
| 754346 | AMG-458 | Clinical trial | PK:YK,MET | - |
| 754348 | PF-03084014 diastereomer 1 | Clinical trial | PSM|APH1|Gamma secretase | - |
| 754349 | Amuvatinib | Clinical trial | RAD51|PK:YK,PDGFR,KIT,FLT3,Multikinase | - |
| 754350 | CB-64D | Clinical trial | Sig2Rec | - |
| 754352 | Adavosertib | Clinical trial | PK:STK,YK,WEE1 | - |
| 754353 | Buparlisib | Clinical trial | PK:PIK3 | - |
| 754354 | GSK-461364 | Clinical trial | PK:STK,PLK1 | - |
| 754355 | Niraparib | FDA approved | PARP|PARP1|PARP2 | - |
| 754356 | PF-562271 | Clinical trial | PK:YK,FAK | - |
| 754357 | RAF-265 | Clinical trial | GTPase|PK:BRAF | - |
| 754358 | TDP-665759 | Clinical trial | Apo|MDM2 | - |
| 754359 | AEG-40730 | Clinical trial | Apo|IAP | - |
| 754360 | MI-219 | Clinical trial | Apo|MDM2 | - |
| 754361 | Astex FGF inhibitor | Clinical trial | PK:YK,FGFR | - |
| 754362 | SB-590885 | Clinical trial | GTPase|PK:YK,BRAF | - |
| 754364 | Targegen B-Raf/PDGFR inhibitor Cpd 6 | Clinical trial | GTPase|PK:YK,PDGFR,BRAF | - |
| 754365 | XR-11576 | Clinical trial | TOP2|TOP1 | - |
| 754366 | XR-5944 | Clinical trial | TOP2|TOP1 | - |
| 754367 | XR-5000 | Clinical trial | TOP2|TOP1 | - |
| 755384 | Pemetrexed | FDA approved | Df|AM|GARTF|DHFR|TYMS | - |
| 755385 | Pictilisib | Clinical trial | PK:PIK3 | - |
| 755386 | Ispinesib | Clinical trial | TUBB|CC|CDH16|KIF11|Kinesin|PK:YK | - |
| 755387 | Sepantronium bromide | Clinical trial | Apo|BIRC5 | - |
| 755389 | Bosutinib | FDA approved | STAT|BCR-ABL|STAT5A/B|PK:YK,LYN,SRC,HCK | - |
| 755400 | Masitinib | FDA approved | PK:YK,PDGFR,FGFR,KIT,FGFR3 | - |
| 755401 | Golotimod | FDA approved | STAT|STAT3 | - |
| 755605 | Enzalutamide | FDA approved | Ho|AR | - |
| 755606 | Cediranib | FDA approved | PK:YK,VEGF,VEGFR,KDR | - |
| 755761 | XAV-939 | Clinical trial | Wnt|PK:YK,TNKS | - |
| 755762 | Luminespib | Clinical trial | HSP90 | - |
| 755763 | Pimasertib | Clinical trial | PK:STK,YK,MAP2K,MAP2K1,MAP2K2 | - |
| 755765 | GW-5074 | Clinical trial | GTPase|PK:RAF,RAF1 | - |
| 755766 | H-89 | Clinical trial | Protein kinase A|PK:STK,AKT1 | - |
| 755769 | LY-294002 | Clinical trial | PK:PIK3 | - |
| 755770 | PD-0325901 | Clinical trial | PK:STK,MAP2K,MAP2K1 | - |
| 755771 | Salirasib | Clinical trial | GTPase|RAS|PK:YK,MTOR | - |
| 755772 | SB-203580 | Clinical trial | PK:STK,MAPK14,PDK1 | - |
| 755773 | 1,9-Pyrazoleanthrone | Clinical trial | PK:STK,MAPK14,MAPK8 | - |
| 755774 | Staurosporine | Clinical trial | PK:PRKCA,SRC,Multikinase | - |
| 755775 | Foretinib | Clinical trial | PK:YK,MET,AXL,VEGFR,KDR,RON,Multikinase | - |
| 755892 | Hydrastinine HCl | Clinical trial | NonCan:Antihemorrhagic | - |
| 755926 | PF-03084014 diastereomer 1 | Clinical trial | PSM|APH1|Gamma secretase | - |
| 755927 | WZ-4002 | Clinical trial | PK:YK,EGFR | - |
| 755980 | Lenvatinib | FDA approved | PK:YK,PDGFR,FGFR,VEGFR,KDR,RET | - |
| 755981 | WP-1034 | Clinical trial | STAT|PK:YK,JAK | - |
| 755982 | Semagacestat | Clinical trial | PSM|APH1|Gamma secretase | - |
| 755983 | BI-2536 | Clinical trial | PK:STK,PLK1 | - |
| 755984 | Pralatrexate | FDA approved | Df|CTNNB1|DHFR | - |
| 755985 | Nelarabine | FDA approved | Ds | 3011155 |
| 755986 | Vismodegib | FDA approved | SMO|PK:YK | - |
| 756641 | ICG-001 | Clinical trial | Apo|Wnt|CTNNB1 | - |
| 756642 | Entinostat | Clinical trial | HDAC | - |
| 756643 | KX-01 | FDA approved | PK:YK,SRC | - |
| 756644 | Rucaparib | FDA approved | PARP|PARP1 | - |
| 756645 | Crizotinib | FDA approved | PK:YK,MET,ALK | 54613769 |
| 756646 | IWR-1 | Clinical trial | Wnt|CTNNB1 | - |
| 756647 | Quizartinib | FDA approved | PK:YK,PDGFR,FLT,KIT,FLT3 | - |
| 756648 | AZD-1480 | Clinical trial | PK:YK,JAK,JAK1,JAK2 | - |
| 756649 | SB-431542 | Clinical trial | TGFB1|PK:STK,GSK3B | - |
| 756650 | RO-4929097 | Clinical trial | PSM|APH1|Gamma secretase | - |
| 756652 | Linsitinib | Clinical trial | PK:YK,IGF1R | - |
| 756653 | SB-239063 | Clinical trial | PK:STK,MAPK14 | - |
| 756654 | ZM-336372 | Clinical trial | GTPase|PK:BRAF,RAF,RAF1 | - |
| 756655 | Bortezomib | FDA approved | PSM | - |
| 756656 | MK-2206 | FDA approved | PK:STK,AKT,AKT1,AKT2,AKT3 | - |
| 756657 | OSU-03012 | Clinical trial | PK:STK,PDK1 | - |
| 756658 | OSU-03013 | Clinical trial | PK:STK,PDK1 | - |
| 756659 | Intedanib | FDA approved | PK:YK,PDGFR,FGFR,VEGFR,FLT3 | - |
| 756660 | Quercetin | Clinical trial | TOP2|AO|NonCan:COMT | - |
| 756662 | sr 13654 | Clinical trial | BIRC5|PK:YK | - |
| 756663 | Obatoclax | Clinical trial | Apo|BCL2 | - |
| 756874 | NU-6027 | Clinical trial | PK:STK,ATR | - |
| 756875 | (+/-)-Nutlin-3 | Clinical trial | Apo|MDM2 | - |
| 756876 | (-)-Nutlin-3 | Clinical trial | Apo|MDM2 | - |
| 756879 | Lificguat | Clinical trial | HYP|HIF1|EPAS1 | - |
| 757148 | AZD-7762 | Clinical trial | PK:STK,CHEK,CHEK1,CHEK2 | - |
| 757149 | Volasertib | Clinical trial | PK:STK,PLK1 | - |
| 757333 | SGI-1776 | Clinical trial | PK:STK,PIM1 | - |
| 757334 | Cpd-401 | Clinical trial | STAT|STAT3 | - |
| 757437 | Salinomycin | FDA approved | Apo|Ab|CD133 | - |
| 757438 | PLX-4720 | Clinical trial | GTPase|PK:BRAF | - |
| 757439 | Neratinib | FDA approved | PK:YK,EGFR,ERBB2 | - |
| 757440 | Deforolimius | Clinical trial | PK:STK,MTOR | - |
| 757441 | Axitinib | FDA approved | PK:YK,PDGFR,VEGFR | 6450551 |
| 757444 | Barasertib | Clinical trial | PK:STK,AURK | - |
| 758005 | Sapitinib | Clinical trial | PK:YK,EGFR,ERBB2 | - |
| 758006 | BLZ-945 | Clinical trial | PK:CSF1R | - |
| 758007 | Tivozanib | FDA approved | PK:YK,MET,PDGFR,FGFR,KIT,VEGFR,FLT3,KDR | - |
| 758242 | Tivantinib | Clinical trial | PK:YK,MET | - |
| 758243 | BMS-754807 | Clinical trial | PK:YK,IGF1R | - |
| 758244 | tepotinib | FDA approved | PK:YK,MET | - |
| 758245 | ENMD-2076 | Clinical trial | PK:STK,AURK,KDR | - |
| 758246 | Trametinib | FDA approved | PK:STK,MAP2K,MAP2K1,MAP2K2 | - |
| 758247 | Palbociclib | FDA approved | PK:STK,CDK,CDK4,CDK6 | - |
| 758248 | RO-5126766 | Clinical trial | GTPase|PK:STK,YK,BRAF,MAP2K,RAF,MAP2K1,MAP2K2 | - |
| 758249 | Pracinostat | Clinical trial | HDAC | - |
| 758250 | SNS-314 | Clinical trial | PK:STK,AURK | - |
| 758251 | Amonafide | Clinical trial | TOP2 | - |
| 758252 | Carfilzomib | FDA approved | PSM | - |
| 758253 | Homoharringtonine | FDA approved | Apo|Ang|Pi | - |
| 758254 | Ixazomib citrate | FDA approved | PSM | - |
| 758256 | PKI-587 | Clinical trial | PK:STK,PIK3,MTOR | - |
| 758257 | LY-2606368 | Clinical trial | PK:STK,CHEK,CHEK1 | - |
| 758484 | Ezatiostat | Clinical trial | GSTP1|PK:STK,ROS1 | - |
| 758485 | BX-912 | Clinical trial | PK:STK,PDK1 | - |
| 758486 | HPI-1 | Clinical trial | SMO|Hg-Smo | - |
| 758487 | Ponatinib | FDA approved | BCR-ABL|PK:YK | - |
| 758488 | Lexibulin | Clinical trial | TUBB|Tu-frag|Tu-stab | - |
| 758489 | Indibulin | Clinical trial | TUBB|Tu-frag|PK:PTK | - |
| 758490 | Picoplatin | Clinical trial | A7|CC|AlkAg|IDNARep | - |
| 758591 | SGX-523 | Clinical trial | PK:YK,MET | - |
| 758773 | Varbulin | Clinical trial | TUBB|Tu-frag | - |
| 758774 | Belinostat | FDA approved | HDAC | - |
| 758871 | AZD-8055 | Clinical trial | PK:STK,MTOR | - |
| 758872 | Saracatinib | Clinical trial | PK:YK,FYN,LYN,FGFR,SRC,BLK,LCK,YES1 | - |
| 758873 | ABT-737 | Clinical trial | Apo|BCL2 | - |
| 759094 | ENMD-2076 Precursor | Clinical trial | PK:STK,AURK | - |
| 759095 | JNJ-38877605 | Clinical trial | PK:YK,MET | - |
| 759096 | Triapine | Clinical trial | Dr|CC | - |
| 759224 | Idelalisib | FDA approved | PK:PIK3 | - |
| 759498 | CYC-116 | Clinical trial | PK:STK,AURK | - |
| 759657 | Quisinostat | Clinical trial | HDAC | - |
| 759658 | 6-(4-pyrimidinyl)-1H-indazole derivative | Clinical trial | PK:STK,PDK1 | - |
| 759659 | Navitoclax | Clinical trial | Apo|BCL2 | - |
| 759660 | OSI-027 | Clinical trial | PK:STK,MTOR | - |
| 759661 | Dovitinib | Clinical trial | PK:YK,MET,PDGFR,EGFR,FGFR,KIT,VEGFR,FGFR1,FGFR3,FLT3 | - |
| 759675 | KW-2449 | Clinical trial | BCR-ABL|PK:STK,AURK,FLT,FLT3 | - |
| 759676 | PI-103 | Clinical trial | PK:PIK3,MTOR | - |
| 759677 | Alisertib | Clinical trial | PK:STK,AURK | - |
| 759905 | 4SC-202 | Clinical trial | HDAC | - |
| 760143 | Mocetinostat | Clinical trial | HDAC | - |
| 760144 | AT-9283 | Clinical trial | PK:STK,AURK | - |
| 760444 | Tipifarnib | Clinical trial | FT|PK:YK | - |
| 760536 | PF-04691502 | Clinical trial | PK:PIK3 | - |
| 760764 | Voreloxin | FDA approved | TOP2 | - |
| 760765 | BMS-690514 | Clinical trial | PK:YK,EGFR,ERBB2,VEGFR | - |
| 760766 | Vandetanib | FDA approved | PK:STK,YK,PDGFR,EGFR,VEGFR,RET | - |
| 760841 | Tandutinib | Clinical trial | PK:YK,PDGFR,FLT,KIT,FLT3 | - |
| 760842 | BIM-46187 | Clinical trial | Apo|GTPase|CASP | - |
| 760843 | Motesanib | Clinical trial | PK:YK,PDGFR,KIT,VEGFR,KDR,RET | - |
| 761068 | Cabozantinib | FDA approved | PK:YK,MET,AXL,KIT,VEGFR,FLT3,RET | - |
| 761069 | AMG-900 | Clinical trial | PK:STK,AURK | - |
| 761070 | VE-821 | Clinical trial | PK:STK,ATR | - |
| 761188 | Rabusertib | Clinical trial | PK:STK,CHEK,CHEK1 | - |
| 761189 | Teglarinad | Clinical trial | Apo|NAMPT | - |
| 761190 | Panobinostat | FDA approved | HDAC | - |
| 761192 | Pevonedistat | Clinical trial | NFkB|NEDD8 | - |
| 761193 | Silmitasertib | Clinical trial | CK2|PK:STK | - |
| 761194 | CUDC-305 | Clinical trial | HSP90 | - |
| 761215 | TAK-733 | Clinical trial | PK:STK,MAP2K,MAP2K1,MAP2K2 | - |
| 761216 | Galunisertib | Clinical trial | TGFB1|PK:GSK3B | - |
| 761217 | Avagacestat | Clinical trial | PSM|APH1|Gamma secretase | - |
| 761266 | Motexafin | Clinical trial | Dr|TXNRD|PK:ROS1 | - |
| 761385 | Sonidegib | FDA approved | SMO|Hg-Smo | - |
| 761387 | CCT-128930 | Clinical trial | PK:STK,AKT,AKT1,AKT2,AKT3 | - |
| 761388 | Plerixafor | FDA approved | CXCR4 | - |
| 761431 | Vemurafenib | FDA approved | PK:YK,BRAF | 42611257 |
| 761432 | Cabazitaxel | FDA approved | TUBB|Tu-stab | 9854073 |
| 761690 | CP-91149 | Clinical trial | PYGL | - |
| 761691 | SCH-1473759 | Clinical trial | PK:STK,AURK | - |
| 761692 | MK-8033 | Clinical trial | PK:YK,MET | - |
| 761693 | Vertex ATR inhibitor Cpd 45 | Clinical trial | PK:STK,ATR | - |
| 761759 | TAK-960 analog | Clinical trial | PK:STK,PLK1 | - |
| 761760 | BMS-536924 | Clinical trial | PK:YK,IGF1R | - |
| 761879 | ITRI-260 | Clinical trial | PK:YK,FLT,FLT3 | - |
| 761910 | Ibrutinib | FDA approved | PK:YK,BTK | - |
| 761931 | KHK-Indazole | Clinical trial | PK:YK,IGF1R | - |
| 762151 | TAK-901 | Clinical trial | PK:STK,AURK | - |
| 762152 | ONX-0914 | Clinical trial | PSM | - |
| 762153 | ST-3595 | Clinical trial | HDAC | - |
| 762154 | Des-fluoro-TAK-960 | Clinical trial | PK:STK,PLK1 | - |
| 762381 | CGI Diphenylurea PK inhibitor | Clinical trial | PK:YK,EPHA4,PDGFR,VEGFR | - |
| 762382 | CH-5132799 | Clinical trial | PK:PIK3 | - |
| 762418 | TAK Plk inhibitor | Clinical trial | PK:STK,PLK1 | - |
| 762419 | CT-32228 | Clinical trial | AGPAT2|PK:YK,VEGFR | - |
| 762521 | RO-4987655 | Clinical trial | PK:STK,MAP2K | - |
| 762598 | BAL-27862 | Clinical trial | TUBB|Tu-frag | - |
| 762672 | BMS-299897 | Clinical trial | PSM|APH1|Gamma secretase | - |
| 762673 | SB-1317 | Clinical trial | PK:STK,CDK,ERK,FLT,JAK,FLT3 | - |
| 762829 | MK-0752 | Clinical trial | PSM|APH1|Gamma secretase | - |
| 763094 | JZL-184 | Clinical trial | MGLL | - |
| 763371 | Ruxolitinib | FDA approved | PK:YK,JAK,JAK1,JAK2 | - |
| 763443 | (+)-Nutlin-3 | Clinical trial | Apo|MDM2 | - |
| 763444 | PF-477736 | Clinical trial | PK:STK,CHEK,CHEK1 | - |
| 763525 | Pluripotin | Clinical trial | GTPase|RAS|RASA1|PK:STK,MAP3K | - |
| 763526 | Crenolanib | Clinical trial | PK:YK,PDGFR,KIT,VEGFR,TEK,FLT3 | - |
| 763527 | JZL-195 | Clinical trial | MGLL | - |
| 763564 | EMD-534085 | Clinical trial | CDH16|KIF11|Kinesin|PK:YK | - |
| 763579 | AT-13387 | Clinical trial | HSP90 | - |
| 763758 | SEN-450 | Clinical trial | SMO | - |
| 763929 | Orantinib | Clinical trial | PK:YK,PDGFR,FGFR,VEGFR,KDR | - |
| 763931 | PF-04217903 | Clinical trial | PK:MET | - |
| 763932 | Regorafenib | FDA approved | GTPase|PK:STK,YK,PDGFR,FGFR,KIT,MAP2K,RAF,VEGFR,KDR,RET,Multikinase | - |
| 764036 | Dinaciclib | Clinical trial | PK:STK,CDK,CDK1,CDK2,CDK5,CDK9 | - |
| 764037 | BP-1-102 | Clinical trial | STAT|IL6|STAT3 | - |
| 764039 | AZD-5363 | Clinical trial | PK:STK,AKT,AKT1,AKT2,AKT3 | - |
| 764040 | Alectinib | FDA approved | PK:YK,ALK | - |
| 764041 | TAE-684 | Clinical trial | PK:YK,ALK | - |
| 764042 | ARRY-162 | FDA approved | PK:STK,MAP2K,MAP2K1,MAP2K2 | - |
| 764043 | (+)-JQ1 | Clinical trial | BRD | - |
| 764090 | BMS-777607 | Clinical trial | PK:MET,RON | - |
| 764091 | Apitolisib | Clinical trial | PK:PIK3,MTOR | - |
| 764092 | GSK-2126458 | Clinical trial | PK:PIK3 | - |
| 764134 | Dabrafenib | FDA approved | PK:BRAF | - |
| 764135 | BMS-599626 | Clinical trial | PK:YK,EGFR,ERBB2 | - |
| 764136 | Abexinostat | Clinical trial | HDAC | - |
| 764237 | Linifanib | Clinical trial | PK:YK,CSF1R,PDGFR,VEGFR,FLT3,KDR | - |
| 764238 | 6-Bromoindirubin-3'-Acetoxime | Clinical trial | PK:GSK3A | - |
| 764239 | AZD-4547 | Clinical trial | PK:YK,FGFR,FGFR1,FGFR2,FGFR3 | - |
| 764276 | t-dcyd | Clinical trial | - | - |
| 764334 | delanzomib | Clinical trial | PSM | - |
| 764481 | Brivanib | Clinical trial | PK:YK,FGFR,VEGFR,FGFR1,FGFR2,FGFR3,KDR | - |
| 764487 | NVP-BGJ398 | FDA approved | PK:FGFR,FGFR1,FGFR2,FGFR3,FGFR4 | - |
| 764488 | Orteronel | Clinical trial | CYP17A1 | - |
| 764515 | PP-242 | Clinical trial | PK:MTOR | - |
| 764516 | ZSTK-474 | Clinical trial | PK:PIK3 | - |
| 764517 | UNC-0638 | Clinical trial | EHMT2|EHMT1/2 | - |
| 764579 | Inolitazone hydrochloride | Clinical trial | PPARG | - |
| 764580 | MK-2461 | Clinical trial | PK:MET,FGFR | - |
| 764581 | ARRY-380 | FDA approved | PK:ERBB2 | - |
| 764582 | 10058-F4 | Clinical trial | MYC | - |
| 764608 | BAL-101553 | Clinical trial | Tu-frag | - |
| 764609 | 10074-G5 | Clinical trial | MYC | - |
| 764658 | INK-128 | Clinical trial | PK:MTOR | - |
| 764659 | SCH-900776 | Clinical trial | PK:STK,CHEK,CHEK1 | - |
| 764755 | Cerulenin | Clinical trial | FAS|FASN|HMGCS1/2 | - |
| 764756 | C-75 | Clinical trial | FAS|FASN | - |
| 764757 | SM-406 | Clinical trial | IAP | - |
| 764764 | ONX-0801 | Clinical trial | TYMS | - |
| 764765 | ARQ-680 | Clinical trial | PK:BRAF | - |
| 764820 | Gandotinib | Clinical trial | PK:JAK,JAK2,JAK3 | - |
| 764821 | Alectinib | FDA approved | PK:YK,ALK | - |
| 764823 | Varlitinib | Clinical trial | PK:YK,EGFR,ERBB2 | - |
| 765395 | MPC-3100 | Clinical trial | HSP90 | - |
| 765396 | BMN-673 | FDA approved | PARP1|PARP2 | - |
| 765435 | Ganetespib | Clinical trial | HSP90 | - |
| 765436 | YK-4-279 | Clinical trial | ERG|ETV | - |
| 765632 | LY-2109761 | Clinical trial | TGFB1|PK:GSK3B | - |
| 765672 | S-49076 | Clinical trial | PK:MET,AXL,FGFR,MERTK | - |
| 765694 | Bosutinib | FDA approved | STAT|BCR-ABL|STAT5A/B|PK:YK,LYN,SRC,HCK | - |
| 765695 | PD 184352 | Clinical trial | PK:MAP2K | - |
| 765775 | Gemcitabine elaidate | Clinical trial | Ds | - |
| 765776 | AZD-3514 | Clinical trial | AR | - |
| 765865 | ASP-3026 | Clinical trial | PK:ALK | - |
| 765866 | Refametinib | Clinical trial | PK:MAP2K,MAP2K1,MAP2K2 | - |
| 765888 | Dacomitinib | FDA approved | PK:EGFR,ERBB2 | - |
| 765889 | ABT-348 | Clinical trial | PK:AURK,VEGFR | - |
| 765898 | GDC-0152 | Clinical trial | IAP | - |
| 765949 | AEE-788 | Clinical trial | PK:EGFR,ERBB2,VEGF,VEGFR | - |
| 765974 | BYL-719 | FDA approved | PK:PIK3 | - |
| 766254 | Oprozomib | Clinical trial | PSM | - |
| 766255 | CT-GSK183 | Clinical trial | PK:IGF1R,ALK | - |
| 766270 | ABT-199 | FDA approved | BCL2 | - |
| 766271 | PHA-665752 | Clinical trial | PK:MET | - |
| 766288 | AMG-208 | Clinical trial | PK:MET | - |
| 766811 | Odanacatib | Clinical trial | CTSB | - |
| 766819 | Sotrastaurin | Clinical trial | PK:PRKCA | - |
| 766820 | LY-2228820 | Clinical trial | PK:MAPK14 | - |
| 766821 | BMS-911543 | Clinical trial | PK:JAK,JAK1,JAK2,JAK3 | - |
| 766824 | CEP-14083 | Clinical trial | PK:ALK | - |
| 766887 | OSI-930 | Clinical trial | PK:PDGFR,KIT,VEGFR,Multikinase | - |
| 766888 | BBOA | Clinical trial | AEMD | - |
| 766906 | MLN-2480 | Clinical trial | PK:BRAF,RAF,RAF1 | - |
| 766907 | Ixazomib | FDA approved | PSM | - |
| 766908 | PD 173074 | Clinical trial | PK:PDGFR,FGFR,SRC,VEGFR,FGFR1,FGFR3 | - |
| 766991 | GSK-690693 | Clinical trial | PK:AKT,AKT1,AKT2,AKT3 | - |
| 766992 | BAY 61-3606 | Clinical trial | PK:SYK | - |
| 767006 | AEW-541 | Clinical trial | PK:YK,IGF1R | - |
| 767048 | BMS-387032 | Clinical trial | PK:CDK,CDK2,CDK7,CDK9 | - |
| 767123 | Saridegib | Clinical trial | SMO | - |
| 767124 | Enzastaurin | Clinical trial | PK:PRKCA,STK,PIK3,AKT | - |
| 767125 | BMN-673 | FDA approved | PARP1|PARP2 | - |
| 767126 | LEQ-506 | Clinical trial | SMO | - |
| 767128 | Birinapant | Clinical trial | IAP | - |
| 767470 | MLN-0905 | Clinical trial | PK:PLK1 | - |
| 767533 | BMN-673 enantiomer | Clinical trial | PARP1 | - |
| 767598 | Momelotinib | Clinical trial | PK:JAK,JAK1,JAK2,JAK3 | - |
| 767599 | I-BET-151 | Clinical trial | BRD | - |
| 767600 | Fedratinib | FDA approved | PK:FLT,JAK,FLT3,JAK2,RET | - |
| 767601 | VX-944 | Clinical trial | IMPDH2|IMPDH1|IMPDH | - |
| 767745 | Pelitrexol | Clinical trial | GARTF | - |
| 767746 | ADW-742 | Clinical trial | PK:IGF1R,KIT | - |
| 767896 | LY-2940680 | Clinical trial | SMO | - |
| 767897 | BPR1J-097 | Clinical trial | PK:FLT,FLT3 | - |
| 767898 | ipatasertib | Clinical trial | PK:AKT,AKT1,AKT2,AKT3 | - |
| 767951 | GSK-1904529A | Clinical trial | PK:IGF1R | - |
| 767952 | rocilinostat | Clinical trial | HDAC | - |
| 767953 | R-1530 | Clinical trial | PK:PDGFR,CDK,FGFR,VEGFR,KDR,Multikinase | - |
| 767954 | EMD-1204831 | Clinical trial | PK:MET | - |
| 768011 | XL-541 | Clinical trial | GEMIN2 | - |
| 768068 | Cobimetinib (isomer 1) | FDA approved | PK:MAP2K,MAP2K1 | - |
| 768069 | Cobimetinib (isomer 1) | FDA approved | PK:MAP2K,MAP2K1 | - |
| 768070 | enantiomer of PF-4176340 | Clinical trial | PK:AKT | - |
| 768071 | enantiomer of PF-4176340 | Clinical trial | PK:AKT | - |
| 768072 | TAK-960 | Clinical trial | PK:PLK1 | - |
| 768073 | LY-2835219 | FDA approved | PK:PIM1,CDK,CDK4,CDK6 | - |
| 768112 | SAR-402674 | Clinical trial | TOP1 | - |
| 768508 | GSK-2636771 | Clinical trial | PK:PIK3,MTOR | - |
| 768509 | SNX-5422 | Clinical trial | HSP90 | - |
| 768536 | BAM7 | Clinical trial | BCL2 | - |
| 768539 | IDH1-Comp 301 | Clinical trial | IDH1 | - |
| 768593 | CEP-9722 | Clinical trial | PARP1 | - |
| 771532 | GDC-0349 | Clinical trial | PK:MTOR,PIM3 | - |
| 771644 | ARQ-621 | Clinical trial | CDH16|KIF11 | - |
| 771649 | ARN-509 | FDA approved | AR | - |
| 771650 | AT-13148 | Clinical trial | PK:AKT,AKT1,AKT2,AKT3 | - |
| 771651 | VX-322 | Clinical trial | PK:FLT,KIT,FLT3 | - |
| 771652 | SAR-125844 | Clinical trial | PK:MET | - |
| 771750 | LY-2874455 | Clinical trial | PK:FGFR,VEGFR,FGFR1,FGFR2,FGFR3,FGFR4 | - |
| 771751 | CUDC-907 | Clinical trial | HDAC|PK:PIK3 | - |
| 771858 | TAK-441 | Clinical trial | SMO | - |
| 772196 | Lestaurtinib | Clinical trial | PK:YK,FLT,NTRK,FLT3,JAK2 | - |
| 772197 | LY-2801653 | Clinical trial | PK:MET,AXL,FLT3,MERTK,MST1R,Multikinase | - |
| 772198 | LY-2090314 | Clinical trial | PK:GSK3A,GSK3B | - |
| 772254 | ARRY-520 Isomer A | Clinical trial | CDH16 | - |
| 772255 | ARRY-520 Isomer A | Clinical trial | CDH16 | - |
| 772290 | Pelitrexol isomer A | Clinical trial | GARTF | - |
| 772291 | Pelitrexol isomer B | Clinical trial | GARTF | - |
| 772351 | XL-888 | Clinical trial | HSP90 | - |
| 772469 | IPI-145 | FDA approved | PK:PIK3 | - |
| 772498 | r406 | Clinical trial | PK:SYK | - |
| 772499 | Vatalanib | Clinical trial | CYP19A1|PK:YK,PDGFR,KIT,VEGFR,KDR | - |
| 772563 | ARRY-704 | Clinical trial | PK:MAP2K,MAP2K1,MAP2K2 | - |
| 772564 | IDH-C227 | Clinical trial | IDH1 | - |
| 772595 | KPT-185 | Clinical trial | XPO1 | - |
| 772868 | LCL-161 | Clinical trial | IAP | - |
| 772885 | PF-4942847 | Clinical trial | HSP90 | - |
| 772886 | Apatinib | Clinical trial | PK:VEGFR | - |
| 772887 | XL-019 | Clinical trial | PK:JAK,JAK2 | - |
| 772920 | ONX-0805 | Clinical trial | PK:JAK,JAK2 | - |
| 772991 | PKM2 (9) | Clinical trial | PKM | - |
| 772992 | Fostamatinib | Clinical trial | Ds|Rs|PK:YK,SYK | - |
| 773094 | R-547 | Clinical trial | PK:CDK,CDK1,CDK2,CDK4 | - |
| 773095 | BGT-226 | Clinical trial | PK:PIK3 | - |
| 773096 | IDH-C35 | Clinical trial | IDH1 | - |
| 773174 | LDHA Inhibitor-33 | Clinical trial | LDHA | - |
| 773230 | AZD-2461 | Clinical trial | PARP1|PARP2 | - |
| 773260 | KPT-251 | Clinical trial | XPO1 | - |
| 773261 | GSK-921 | Clinical trial | CDH16|KIF11 | - |
| 773262 | VX-689 | Clinical trial | PK:AURK | - |
| 773264 | R-306465 | Clinical trial | HDAC | - |
| 773265 | B-7100 | Clinical trial | HSP90 | - |
| 773394 | AT-7519 | Clinical trial | RNA polymerase I|PK:CDK,CDK1,CDK2,CDK4,CDK6 | - |
| 774651 | Cilengitide | Clinical trial | Ang|ITG | - |
| 774769 | NMS-E628 | FDA approved | PK:ROS1,ALK | - |
| 774829 | I-BET-762 | Clinical trial | BRD | - |
| 774830 | Milciclib | Clinical trial | PK:CDK,CDK1,CDK2,CDK4,CDK5,Multikinase | - |
| 774831 | Rebastinib | Clinical trial | BCR-ABL|PK:LYN,FGFR,SRC,VEGFR,TEK | - |
| 774901 | AZD-2858 | Clinical trial | Wnt|PK:GSK3A | - |
| 774911 | BAY-1000394 | Clinical trial | PK:CDK | - |
| 775018 | LDHA Cmp 35 | Clinical trial | LDHA | - |
| 775306 | P-529 | Clinical trial | PK:PIK3,AKT,FGFR,MTOR,VEGFR | - |
| 775351 | Pomalidomide | FDA approved | Immunomodulatory | - |
| 775636 | SCH-772984 | Clinical trial | PK:ERK,MAP3K,MAPK1 | - |
| 775637 | AMD-070 | Clinical trial | CXCR4 | - |
| 775665 | VX-702 | Clinical trial | PK:MAPK14 | - |
| 775727 | Torin2 | Clinical trial | PK:MTOR | - |
| 775771 | BMS-863233 | Clinical trial | PK:CDC7,CDK7,CDK9 | - |
| 775772 | PF-04449913 | FDA approved | SMO | - |
| 776017 | Telatinib | Clinical trial | PK:PDGFR,KIT,VEGFR,KDR | - |
| 776043 | CEP-32496 | Clinical trial | PK:BRAF | - |
| 776066 | AZD-1208 | Clinical trial | PK:PIM1,PIM2,PIM3 | - |
| 776422 | LDK-378 | FDA approved | PK:ALK | - |
| 776762 | EXEL-7647 | Clinical trial | PK:EGFR,ERBB2,SRC,VEGFR | - |
| 776786 | P505-15 | Clinical trial | PK:SYK | - |
| 776787 | AZD-3463 | Clinical trial | PK:IGF1R,ALK | - |
| 776790 | MK-0429 | Clinical trial | ITG | - |
| 776821 | CCT-241533 | Clinical trial | PK:CHEK,CHEK2 | - |
| 776996 | PI-103 | Clinical trial | PK:PIK3,MTOR | - |
| 777109 | E-7438 | FDA approved | EZH2 | - |
| 777194 | Daporinad | Clinical trial | NAMPT|PK:YK | - |
| 777425 | GDC-0032 | Clinical trial | PK:PIK3 | - |
| 777445 | GSK-1070916 | Clinical trial | PK:AURK | - |
| 777446 | Talmapimod | Clinical trial | PK:MAPK14 | - |
| 777447 | VTX-2337 | Clinical trial | TLR8 | - |
| 777448 | PFI-1 | Clinical trial | BRD | - |
| 777571 | BIX-01294 | Clinical trial | EHMT2|EHMT1/2 | - |
| 777572 | AZD-8186 | Clinical trial | PI3KB|PK:PIK3 | - |
| 777573 | E-7820 | Clinical trial | Ang|ITG | - |
| 777586 | 5-aza-T-dCyd | Clinical trial | - | - |
| 777638 | AZD-6738 | Clinical trial | PK:ATR | - |
| 777639 | LGK-974 | Clinical trial | Wnt|PORCN | - |
| 777671 | BRD-4770 | Clinical trial | EHMT2|EHMT1/2 | - |
| 777718 | VE-822 | Clinical trial | PK:ATR | - |
| 777877 | PF-4989216 | Clinical trial | PK:PIK3 | - |
| 777878 | TABRECTA | FDA approved | PK:MET | - |
| 777879 | AM-5992 | Clinical trial | PK:CDK,FLT,FLT3 | - |
| 778304 | Encorafenib | FDA approved | PK:BRAF | - |
| 778305 | Afuresertib | Clinical trial | PK:AKT,AKT1,AKT2,AKT3 | - |
| 778364 | Defactinib | Clinical trial | PK:FAK | - |
| 778365 | EPZ-5676 | Clinical trial | DOT1L | - |
| 778366 | EXEL-2280 | Clinical trial | PK:IGF1R,AURK,FGFR,SRC | - |
| 778367 | ARRY-614 | Clinical trial | PK:MAPK14 | - |
| 778368 | GSK-2141795 | Clinical trial | PK:AKT | - |
| 778448 | Ombrabulin | Clinical trial | TUBB|Tu-frag | - |
| 778590 | Cobimetinib (isomer 1) | FDA approved | PK:MAP2K,MAP2K1 | - |
| 778746 | FH-535 | Clinical trial | PPARG | - |
| 778747 | OTX-015 | Clinical trial | BRD | - |
| 778809 | TAK-632 | Clinical trial | PK:BRAF | - |
| 778810 | VS-5584 | Clinical trial | PK:PIK3,MTOR | - |
| 778909 | LEE-011 | FDA approved | PK:CDK,CDK4,CDK6 | - |
| 779217 | osimertinib | FDA approved | PK:EGFR | - |
| 779218 | CEP-28122 | Clinical trial | PK:ALK | - |
| 779404 | RG-7388 | Clinical trial | MDM2 | - |
| 779405 | CO-1686 | FDA approved | PK:EGFR | - |
| 779407 | GNE-617 | Clinical trial | NAMPT | - |
| 779408 | Deltarasin | Clinical trial | PDE6D | - |
| 780019 | PD183805 | Clinical trial | PK:EGFR,ERBB2 | - |
| 780020 | spebrutinib | Clinical trial | PK:BTK | - |
| 780041 | GSK-126 | Clinical trial | EZH2 | - |
| 780042 | CP-724714 | Clinical trial | PK:ERBB2 | - |
| 780043 | EPZ-004777 | Clinical trial | DOT1L | - |
| 780108 | PF-06463922 | FDA approved | PK:ROS1,ALK | - |
| 780163 | SOMCL-12-81 | Clinical trial | PK:ALK | - |
| 780203 | selinexor | FDA approved | XPO1 | - |
| 780204 | TAS-116 | Clinical trial | HSP90 | - |
| 780205 | dimethylfasudil | Clinical trial | RHO | - |
| 780249 | AZD-6738 | Clinical trial | PK:ATR | - |
| 780250 | AZD-6738 ( R,S-isomer) | Clinical trial | PK:ATR | - |
| 780290 | SAR-260301 (enantiomer 1) | Clinical trial | PI3KB | - |
| 780291 | SAR-260301 (enantiomer 1) | Clinical trial | PI3KB | - |
| 780404 | AZ-505 | Clinical trial | SETD8|SMYD2 | - |
| 780812 | BMS-906024 | Clinical trial | APH1|Gamma secretase | - |
| 780965 | MK-0731 | Clinical trial | CDH16|KIF11 | - |
| 781008 | maritoclax | Clinical trial | MCL1 | - |
| 781009 | MI-773 | Clinical trial | MDM2 | - |
| 781016 | BAY-87-2243 | Clinical trial | HIF1 | - |
| 781148 | CEP-37440 | Clinical trial | PK:ALK,FAK | - |
| 781343 | GDC-0994 | Clinical trial | PK:ERK,MAP3K,MAPK1 | - |
| 781344 | NMS-1286937 | Clinical trial | PK:PLK1 | - |
| 781409 | AGI-6780 | Clinical trial | IDH2 | - |
| 781417 | RN-486 | Clinical trial | PK:BTK | - |
| 781468 | CUDC-427 | Clinical trial | IAP | - |
| 781469 | BMS-833923 | Clinical trial | SMO | - |
| 781470 | PF-03758309 | Clinical trial | PK:PAK4 | - |
| 781514 | AMG-925 | Clinical trial | PK:CDK,CDK4,CDK6,FLT3 | - |
| 781515 | AMG-232 | Clinical trial | MDM2 | - |
| 781516 | entosplenitib | Clinical trial | PK:SYK | - |
| 781556 | JNJ-42756493 | FDA approved | PK:FGFR,FGFR1,FGFR2,FGFR3,FGFR4 | - |
| 781626 | Pacritinib | Clinical trial | PK:YK,JAK,JAK2 | - |
| 781627 | GSK-2606414 | Clinical trial | PK:EIF2AK3 | - |
| 781652 | ningetinib | Clinical trial | PK:MET | - |
| 781761 | LY-3009120 | Clinical trial | PK:BRAF,RAF1 | - |
| 782006 | PTC-691 | Clinical trial | PK:RET | - |
| 782007 | AZ-628 | Clinical trial | PK:BRAF | - |
| 782017 | H-89 | Clinical trial | Protein kinase A|PK:STK,AKT1 | - |
| 782121 | volitinib | Clinical trial | PK:MET | - |
| 782122 | AMG-511 | Clinical trial | PK:PIK3 | - |
| 782125 | JNJ-54302833 | Clinical trial | FASN | - |
| 782153 | MG-132 | Clinical trial | PSM | - |
| 782164 | CX-5461 | Clinical trial | RNA polymerase I | - |
| 782310 | CPI-169 | Clinical trial | EZH2 | - |
| 782351 | tofacitinib | FDA approved | PK:JAK,JAK1,JAK3 | - |
| 782362 | PWT-33597 | Clinical trial | PK:PIK3,MTOR | - |
| 782363 | CH-5183284 | Clinical trial | PK:PDGFR,FGFR,VEGFR,FGFR1,FGFR2,FGFR3 | - |
| 782457 | VBY-825 | Clinical trial | CTSB | - |
| 782549 | Defactinib | Clinical trial | PK:FAK | - |
| 782579 | PCI-27483 | Clinical trial | F7 | - |
| 782762 | E-3810 | Clinical trial | PK:PDGFR,FGFR,VEGFR | - |
| 782763 | cs-1730 | Clinical trial | BRD | - |
| 783015 | CGM-097 | Clinical trial | MDM2 | - |
| 783102 | VS-4718 | Clinical trial | PK:FAK | - |
| 783107 | E-7449 | Clinical trial | PARP1|PARP2 | - |
| 783249 | JNJ-26483327 | Clinical trial | PK:EGFR,ERBB2,SRC,VEGFR,RET,Multikinase | - |
| 783272 | JNJ-47117096 | Clinical trial | PK:MELK | - |
| 783294 | VT-464 | Clinical trial | CYP17A1 | - |
| 783296 | poziotinib | Clinical trial | PK:EGFR,ERBB2,Multikinase | - |
| 783332 | EPZ-5687 | Clinical trial | EZH2 | - |
| 783333 | SGI-1027 | Clinical trial | DNMT | - |
| 783334 | RG-108 | Clinical trial | DNMT | - |
| 783360 | IM-25 | Clinical trial | DNMT | - |
| 783415 | CB-839 | Clinical trial | GLS | - |
| 783916 | pyridoclax | Clinical trial | MCL1 | - |
| 783917 | GSK-2879552 | Clinical trial | KDM1A | - |
| 784284 | P-1446 | Clinical trial | PK:CDK,CDK1,CDK2,CDK4,CDK7,CDK9 | - |
| 784415 | Danusertib | Clinical trial | BCR-ABL|PK:YK,AURK,FGFR,RET | - |
| 784590 | altiratinib | Clinical trial | PK:MET,NTRK,VEGFR,TEK,KDR | - |
| 784591 | CCT-251545 | Clinical trial | Wnt|PK:CDK19 | - |
| 784722 | aldoxorubicin | Clinical trial | TOP2 | - |
| 784815 | AZD-3147 | Clinical trial | PK:MTOR | - |
| 784817 | A-1210477 | Clinical trial | MCL1 | - |
| 784856 | CPI-0610 | Clinical trial | BRD | - |
| 785004 | MLN-7243 | Clinical trial | UB-activating | - |
| 785117 | PQR-309 | Clinical trial | PK:PIK3,MTOR | - |
| 785222 | BMS-983970 | Clinical trial | APH1|Gamma secretase | - |
| 785299 | EPZ-015666 | Clinical trial | PRMT5 | - |
| 785300 | BLU-9931 | Clinical trial | PK:FGFR,FGFR1,FGFR2,FGFR3,FGFR4 | - |
| 785306 | TAS-115 | Clinical trial | PK:MET,VEGFR | - |
| 785345 | Bet-BAY-002 | Clinical trial | BRD | - |
| 785497 | INCB-024360 | FDA approved | IDO1 | - |
| 785570 | LOXO-101 | FDA approved | PK:NTRK | - |
| 785657 | RX-3117 | Clinical trial | DNMT | - |
| 786098 | BAY-1143572 | Clinical trial | PK:CDK,CDK9 | - |
| 786099 | AZD-8835 | Clinical trial | PK:PIK3 | - |
| 786100 | CB-5083 | Clinical trial | VCP | - |
| 786959 | AZD-9496 | Clinical trial | SERD | - |
| 787025 | BAY-1161909 | Clinical trial | IDUA | - |
| 787026 | BAY-1217389 | Clinical trial | IDUA | - |
| 787027 | EGF-816 | Clinical trial | PK:EGFR | - |
| 787038 | AC-710 | Clinical trial | PK:CSF1R,PDGFR,FLT3 | - |
| 787039 | MI-503 | Clinical trial | KMT2A | - |
| 787047 | AZD-3965 | Clinical trial | SLC16A1|SLC16A7 | - |
| 787048 | azd5582 | Clinical trial | IAP | - |
| 787081 | SR 9243 | Clinical trial | NR1H1/2 | - |
| 787137 | AMG-319 | Clinical trial | PK:PIK3 | - |
| 787251 | lomeguatrib | Clinical trial | MGMT | - |
| 787252 | TAE-226 | Clinical trial | PK:IGF1R,FAK | - |
| 787253 | LY-3039478 | Clinical trial | NOTCH | - |
| 787269 | SW-033291 | Clinical trial | HPGD | - |
| 787312 | PT-2385 | Clinical trial | EPAS1 | - |
| 787326 | GDC-0810 | Clinical trial | SERD | - |
| 787457 | brigatinib | FDA approved | PK:YK,IGF1R,ALK,EGFR | - |
| 787780 | sabutoclax | Clinical trial | MCL1 | - |
| 787827 | CFG-920 | Clinical trial | CYP17A1 | - |
| 787846 | gilteritinib | FDA approved | PK:AXL,FLT3 | - |
| 787880 | OTS-964 | Clinical trial | PK:PBK | - |
| 787960 | UMI-77 | Clinical trial | MCL1 | - |
| 787962 | KU-55933 | Clinical trial | PK:ATM | - |
| 788120 | enasidenib | FDA approved | IDH1|IDH2 | - |
| 788121 | AZD-3759 | Clinical trial | PK:EGFR | - |
| 788186 | Bafetinib | Clinical trial | BCR-ABL|PK:YK,FYN,LYN | - |
| 788203 | sitravatinib | Clinical trial | PK:PDGFR,AXL,NTRK,KDR,RET | - |
| 788365 | PF-06747775 | Clinical trial | PK:EGFR | - |
| 788794 | A-911 | Clinical trial | PK:CDK,CDK9 | - |
| 788900 | napabucasin | Clinical trial | CTNNB1|STAT3 | - |
| 788948 | Vistonuridine | FDA approved | TUBB|FU-Antidote | - |
| 788992 | OICR-9429 | Clinical trial | WDR5 | - |
| 789040 | CBL-0137 | Clinical trial | - | - |
| 789041 | GSK-295 | Clinical trial | CENP | - |
| 789042 | LOR-253 | Clinical trial | KLF4|MYC|MTF1 | - |
| 789043 | ARV-825 | Clinical trial | BRD | - |
| 789044 | CCT-271850 | Clinical trial | IDUA | - |
| 789099 | LY-3154567 | Clinical trial | NAMPT | - |
| 789102 | ivosidenib | FDA approved | IDH1 | - |
| 789223 | AMG-337 | Clinical trial | PK:MET | - |
| 789300 | PLX-3397 | FDA approved | PK:CSF1R,KIT,FLT3 | - |
| 789722 | Litronesib | Clinical trial | TUBB|CDH16|KIF11 | - |
| 789797 | SW-044248 | Clinical trial | TOP1 | - |
| 789925 | ABL-001 | FDA approved | BCR-ABL | - |
| 789968 | LY-3023414 | Clinical trial | PK:PIK3,MTOR | - |
| 789969 | SB-202190 | Clinical trial | PK:MAPK14 | - |
| 790182 | alofanib | Clinical trial | PK:FGFR | - |
| 790865 | EPZ-020411 | Clinical trial | PRMT6 | - |
| 791059 | MGCD-265 | Clinical trial | PK:MET,VEGFR | - |
| 791163 | RG-7602 | Clinical trial | PK:CHEK1 | - |
| 791164 | acalabrutinib | FDA approved | PK:BTK | - |
| 791226 | SAR-245409 | Clinical trial | PK:PIK3 | - |
| 791227 | XL-147 | Clinical trial | PK:PIK3 | - |
| 791328 | ARQ-092 | Clinical trial | PK:AKT | - |
| 791495 | GDC-0339 | Clinical trial | PK:PIM1,PIM2,PIM3 | - |
| 791496 | APR-246 | Clinical trial | Apo | - |
| 791648 | PF-2771 | Clinical trial | CENP | - |
| 791783 | eFT-508 | Clinical trial | MKNK1/2 | - |
| 791785 | Sapacitabine | Clinical trial | Ds | - |
| 791966 | CFI-400945 | Clinical trial | PK:PLK1 | - |
| 791967 | TAK-659 (isomer 1) | Clinical trial | PK:SYK | - |
| 791968 | TAK-659 (isomer 1) | Clinical trial | PK:SYK | - |
| 792847 | INCB-047775 | Clinical trial | PK:AKT | - |
| 792848 | olmutinib | FDA approved | PK:EGFR,BTK,JAK3 | - |
| 792849 | itacitinib | Clinical trial | PK:JAK1 | - |
| 792955 | GSK-2194069 | Clinical trial | FAS|FASN | - |
| 792956 | AZD-0156 | Clinical trial | PK:ATM | - |
| 792969 | VX-984 | Clinical trial | PK:PRKDC | - |
| 792970 | KPT-9274 | Clinical trial | PK:PAK4 | - |
| 792971 | CC-223 | Clinical trial | PK:MTOR | - |
| 792987 | GDC-0084 | Clinical trial | PK:PIK3,MTOR | - |
| 792996 | ARQ-087 | Clinical trial | PK:FGFR | - |
| 792997 | ARQ-087_Peak 2 | Clinical trial | - | - |
| 793103 | ABBV-075 | Clinical trial | BRD | - |
| 793148 | RX-5902 | Clinical trial | - | - |
| 793149 | BAY-876 | Clinical trial | SLC2A1 | - |
| 793150 | ensartinib | Clinical trial | PK:ALK | - |
| 793151 | CC-115 | Clinical trial | PK:MTOR | - |
| 793322 | naquotinib | Clinical trial | PK:EGFR | - |
| 793323 | BGB-283 | Clinical trial | PK:BRAF | - |
| 793324 | BAY-1125976 | Clinical trial | PK:AKT,AKT2 | - |
| 793430 | CPI-1205 | Clinical trial | EZH2 | - |
| 793585 | LY-3177833 | Clinical trial | PK:CDC7,CDK7 | - |
| 793677 | ASP-5878 | Clinical trial | PK:FGFR | - |
| 793679 | CNDAC | Clinical trial | - | - |
| 793726 | CCT-245737 | Clinical trial | PK:CHEK1 | - |
| 793727 | CCT-251921 | Clinical trial | PK:CDK,CDK19 | - |
| 794109 | LGH-447 | Clinical trial | PK:PIM1 | - |
| 794442 | PQR-620 | Clinical trial | PK:MTOR | - |
| 794443 | KPT-8602 | Clinical trial | XPO1 | - |
| 794487 | BAY-1436032 | Clinical trial | IDH1 | - |
| 794589 | NTRC-0066-0 | Clinical trial | PK:TTK | - |
| 794590 | BAY-1082439 | Clinical trial | PK:PIK3 | - |
| 794646 | AMG-51 | Clinical trial | PK:MET | - |
| 795067 | IPI-549 | Clinical trial | - | - |
| 795142 | M2698 | Clinical trial | PK:AKT,AKT1,AKT2,AKT3 | - |
| 795384 | serabelisib | Clinical trial | - | - |
| 795718 | BLU-554 | Clinical trial | PK:FGFR,FGFR4 | - |
| 795781 | GSK-2795039 | Clinical trial | - | - |
| 796100 | PF-06840003 | Clinical trial | IDO1 | - |
| 796101 | ABC-294640 | Clinical trial | SPHK2 | - |
| 796433 | PF-04136309 | Clinical trial | - | - |
| 797172 | A-1331852 | Clinical trial | - | - |
| 797393 | AT-265 | Clinical trial | HSP90 | - |
| 797653 | WT-161 | Clinical trial | HDAC | - |
| 797769 | ABC-1183 | Clinical trial | - | - |
| 797770 | CEP-40783 | Clinical trial | - | - |
| 797771 | ulixertinib | Clinical trial | PK:ERK | - |
| 797772 | selonsertib | Clinical trial | PK:MAP3K5 | - |
| 797932 | PLX-8394 | Clinical trial | PK:BRAF | - |
| 797933 | tirabrutinib | Clinical trial | PK:BTK | - |
| 797934 | Plinabulin | Clinical trial | - | - |
| 797937 | Sulfatinib | FDA approved | PK:YK,FGFR,KDR | - |
| 797938 | AZD-5153 | Clinical trial | - | - |
| 798200 | TP-0903 | Clinical trial | PK:AXL | - |
| 798201 | VH-298 | Clinical trial | VHL | - |
| 798202 | fenebrutinib | Clinical trial | PK:BTK | - |
| 798303 | BPTES | Clinical trial | GLS | - |
| 798304 | EC-330 | Clinical trial | MDM2 | - |
| 798517 | SAR-20347 | Clinical trial | PK:TYK2 | - |
| 798799 | GS-9901 | Clinical trial | - | - |
| 798846 | S-63845 | Clinical trial | - | - |
| 799644 | DDP-38003 | Clinical trial | - | - |
| 799645 | Aurigene Cmp 4 | Clinical trial | - | - |
| 799771 | BMS-988205 | Clinical trial | IDO1 | - |
| 799908 | GNE-140 | Clinical trial | LDHA | - |
| 800019 | PF-06821497 | Clinical trial | EZH2 | - |
| 800030 | LXS-196 | Clinical trial | PK:PRKCA | - |
| 800283 | H3B-6527 | Clinical trial | PK:FGFR | - |
| 800404 | GSK-3326595 | Clinical trial | PRMT5 | - |
| 800405 | umbralisib | FDA approved | - | - |
| 800522 | TPX-0005 | Clinical trial | PK:ROS1,ALK | - |
| 800525 | BAY-1895344 | Clinical trial | PK:ATR | - |
| 800729 | GDC-0077 | Clinical trial | - | - |
| 800888 | CFI-402257 | Clinical trial | IDUA|PK:TTK | - |
| 800890 | MSC-2530818 | Clinical trial | PK:CDK | - |
| 800892 | evobrutinib | Clinical trial | PK:BTK | - |
| 800893 | milademetan | Clinical trial | MDM2 | - |
| 801082 | BLU-285 | FDA approved | - | - |
| 801089 | PRN-1371 | Clinical trial | PK:FGFR | - |
| 801230 | BMS-986158 | Clinical trial | - | - |
| 801661 | TAK-931 | Clinical trial | PK:CDC7 | - |
| 801812 | CPI-444 | Clinical trial | - | - |
| 801813 | AZD-4205 | Clinical trial | PK:JAK | - |
| 801845 | - | - | - | 459278582 |
| 802004 | - | - | - | 459276951 |
| 802100 | ON-123300 | Clinical trial | PK:CDK,RET | - |
| 802101 | AZD-4635 | Clinical trial | - | - |
| 802450 | BAY-1251152 | Clinical trial | - | - |
| 802451 | LY-3200882 | Clinical trial | - | - |
| 802548 | AZD-5069 | Clinical trial | CXCR2 | - |
| 802820 | FT-1518 | Clinical trial | PK:MTOR | - |
| 802821 | PQR-530 | Clinical trial | PK:MTOR | - |
| 802822 | nedisertib | Clinical trial | - | - |
| 803014 | tenalisib | Clinical trial | - | - |
| 803247 | CB-1158 | Clinical trial | - | - |
| 803248 | MTX-211 | Clinical trial | PK:EGFR | - |
| 803408 | EED-226 | Clinical trial | EED | - |
| 803409 | BAY-1816032 | Clinical trial | PK:BUB1 | - |
| 803410 | LY-3214996 | Clinical trial | PK:ERK | - |
| 803552 | SGN-2FF | Clinical trial | - | - |
| 803600 | AG-881 | Clinical trial | IDH1|IDH2 | - |
| 803601 | LYC-55716 | Clinical trial | - | - |
| 803789 | AZD-1390 | Clinical trial | PK:ATM | - |
| 803790 | Aurigene Cpm 16 | Clinical trial | - | - |
| 804040 | E-7046 | Clinical trial | - | - |
| 804041 | AMG-176 | Clinical trial | - | - |
| 804253 | pamiparib | Clinical trial | PARP1|PARP2 | - |
| 804254 | SHP-099 | Clinical trial | PTPN11 | - |
| 804518 | BAY-1163877 | Clinical trial | PK:FGFR | - |
| 804520 | HDM-201 | Clinical trial | MDM2 | - |
| 804521 | S-222611 | Clinical trial | PK:EGFR,ERBB2 | - |
| 804861 | ASTX-660 | Clinical trial | IAP | - |
| 804862 | EPZ-031686 | Clinical trial | SMYD3 | - |
| 804962 | FGF-401 | Clinical trial | PK:FGFR | - |
| 805149 | TP-3654 | Clinical trial | PK:PIM1,PIM3 | - |
| 805500 | SEL-120 | Clinical trial | PK:CDK | - |
| 805596 | IDF-11774 | Clinical trial | - | - |
| 805746 | CC-671 | Clinical trial | PK:TTK | - |
| 806387 | CYC-065 | Clinical trial | PK:CDK | - |
| 806388 | E-7090 | Clinical trial | PK:FGFR | - |
| 806595 | PLX-51107 | Clinical trial | - | - |
| 806812 | RG-6016 | Clinical trial | - | - |
| 807047 | LXH-254 | Clinical trial | PK:RAF | - |
| 807055 | AZD-5991 | Clinical trial | - | - |
| 807398 | INCB-057643 | Clinical trial | - | - |
| 807626 | JNJ-3887618 | Clinical trial | - | - |
| 807627 | BMS-986195 | Clinical trial | PK:BTK | - |
| 808292 | SGI-110 | Clinical trial | DNMT | - |
| 808507 | PF-6459988 | Clinical trial | PRMT5|PK:EGFR | - |
| 808789 | RG-7741 | Clinical trial | - | - |
| 808790 | AZD-0364 | Clinical trial | PK:ERK | - |
| 808792 | CC-90003 | Clinical trial | PK:ERK | - |
| 809099 | EPZ-011989 | Clinical trial | EZH2 | - |
| 809100 | RG-7112 | Clinical trial | MDM2 | - |
| 809251 | ETC-159 | Clinical trial | - | - |
| 809252 | PF-06855800 | Clinical trial | PRMT5 | - |
| 809694 | BOS-172722 | Clinical trial | - | - |
| 809970 | LOXO-195 | Clinical trial | - | - |
| 809971 | S-64315 | Clinical trial | - | - |
| 809972 | IACS-10759 | Clinical trial | - | - |
| 809973 | BAY-2402234 | Clinical trial | DHODH | - |
| 810114 | vecabrutinib | Clinical trial | PK:BTK | - |
| 810341 | PF-6459988 | Clinical trial | PRMT5|PK:EGFR | - |
| 810717 | CG-806 | Clinical trial | PK:BTK | - |
| 811429 | BLU-667 | FDA approved | PK:RET | - |
| 811953 | IACS-8968 | Clinical trial | IDO1 | - |
| 812052 | CH-7057288 | Clinical trial | - | - |
| 812172 | ARS-1620 | Clinical trial | KRAS | - |
| 812415 | ABBV-744 | Clinical trial | - | - |
| 812727 | relacorilant | Clinical trial | - | - |
| 812728 | AZD-4320 | Clinical trial | - | - |
| 812901 | PRN-1008 | Clinical trial | PK:BTK | - |
| 812902 | - | - | - | 440806897 |
| 812926 | TAS-6417 | Clinical trial | PK:EGFR | - |
| 812927 | PF-06873600 | Clinical trial | PK:CDK | - |
| 812928 | IDH-305 | Clinical trial | IDH1 | - |
| 813380 | AZD-3229 | Clinical trial | - | - |
| 813381 | valemetostat | Clinical trial | EZH2 | - |
| 813488 | futibutinib | Clinical trial | PK:FGFR | - |
| 813783 | Trabectedin | FDA approved | A2 | - |
| 813859 | RGX-104 | Clinical trial | - | - |
| 813862 | Lapachone | Clinical trial | TOP2|TOP1 | - |
| 814025 | LSZ-102 | Clinical trial | SERD | - |
| 816024 | - | - | - | 440815726 |
| 816437 | - | - | - | 440816497 |
| 816554 | - | - | - | 440796500 |
| 816555 | - | - | - | 440795955 |
| 816556 | - | - | - | 440804240 |
| 816863 | - | - | - | 440815048 |
| 816987 | - | - | - | 440795760 |
| 817040 | - | - | - | 440810316 |
| 817041 | - | - | - | 440797093 |
| 817042 | - | - | - | 440798549 |
| 817043 | - | - | - | 440812305 |
| 818002 | - | - | - | 440798412 |
| 818003 | - | - | - | 440798565 |
| 818432 | - | - | - | 440798552 |
| 818433 | - | - | - | 440796328 |
| 818434 | - | - | - | 440798555 |
| 818435 | - | - | - | 440798527 |
| 818619 | - | - | - | 440807030 |
| 818620 | - | - | - | 440804300 |
| 818621 | - | - | - | 440808209 |
| 819210 | - | - | - | 440806890 |
| 819211 | - | - | - | 440812602 |
| 819558 | - | - | - | 440798408 |
| 820052 | - | - | - | 440809833 |
| 820283 | - | - | - | 440802431 |
| 820784 | - | - | - | 440799577 |
| 820832 | - | - | - | 440798529 |
| 820918 | - | - | - | 440798792 |
| 820919 | - | - | - | 440807423 |
| 821656 | - | - | - | 440810462 |
| 822744 | - | - | - | 440809732 |
| 823658 | - | - | - | 440812495 |
| 823659 | - | - | - | 440815776 |
| 823806 | - | - | - | 440802233 |
| 823807 | - | - | - | 440796275 |
| 824183 | - | - | - | 440814994 |
| 824184 | - | - | - | 440799266 |
| 824722 | - | - | - | 440801661 |
| 824723 | - | - | - | 440795818 |
| 825088 | - | - | - | 440807533 |
| 825089 | - | - | - | 440804121 |
| 825217 | - | - | - | 440799301 |
| 825254 | - | - | - | 440801555 |
| 825282 | - | - | - | 440802755 |
| 825286 | - | - | - | 440816002 |
| 825287 | - | - | - | 440813265 |
| 825331 | - | - | - | 440796129 |
| 825332 | - | - | - | 440804307 |
| 825519 | - | - | - | 440802469 |
| 825520 | - | - | - | 440805236 |
| 825521 | - | - | - | 440813474 |
| 825522 | - | - | - | 440807937 |
| 825523 | - | - | - | 440816160 |
| 825713 | - | - | - | 440800094 |
| 825775 | - | - | - | 440796922 |
| 825827 | - | - | - | 440800120 |
| 825956 | - | - | - | 440799812 |
| 826039 | - | - | - | 440800033 |
| 826040 | - | - | - | 440797119 |
| 826119 | - | - | - | 440797111 |
| 826275 | - | - | - | 440802518 |
| 826942 | - | - | - | 440813546 |
| 827275 | - | - | - | 440805393 |
| 827675 | - | - | - | 440808421 |
| 827676 | - | - | - | 440816625 |
| 827802 | - | - | - | 440813863 |
| 827886 | - | - | - | 440814015 |
| 828250 | - | - | - | 440802509 |
| 828251 | - | - | - | 440799695 |
| 828252 | - | - | - | 440807963 |
| 828316 | - | - | - | 440816194 |
| 828317 | - | - | - | 440796775 |
| 828318 | - | - | - | 440799724 |
| 828319 | - | - | - | 440796816 |
| 828583 | - | - | - | 440805582 |
| 828584 | - | - | - | 440797141 |
| 828717 | - | - | - | 440802545 |
| 828852 | - | - | - | 440811289 |
| 828853 | - | - | - | 440797285 |
| 828939 | - | - | - | 441612643 |
| 829066 | - | - | - | 441613449 |
| 829498 | - | - | - | 441613247 |
| 830173 | - | - | - | 441614055 |
| 830201 | - | - | - | 441612883 |
| 830202 | - | - | - | 441613877 |
| 830368 | - | - | - | 441612832 |
| 830911 | - | - | - | 441612801 |
| 830912 | - | - | - | 441613985 |
| 831147 | - | - | - | 441613338 |
| 831270 | - | - | - | 441613161 |
| 831271 | - | - | - | 441613761 |
| 831453 | - | - | - | 443699379 |
| 831868 | - | - | - | 443698476 |
| 832046 | - | - | - | 443698883 |
| 832261 | - | - | - | 443699440 |
| 832262 | - | - | - | 443699552 |
| 832263 | - | - | - | 443698610 |
| 832522 | - | - | - | 443699273 |
| 832523 | - | - | - | 443698716 |
| 832772 | - | - | - | 459277194 |
| 832937 | - | - | - | 459278590 |
| 832938 | - | - | - | 459277772 |
| 833292 | - | - | - | 459277627 |
| 833390 | - | - | - | 459277077 |
| 833745 | - | - | - | 459278422 |
| 833746 | - | - | - | 459278165 |
| 833899 | - | - | - | 459277050 |
| 833900 | - | - | - | 459278419 |
| 833901 | - | - | - | 459278703 |
| 833973 | - | - | - | 459278474 |
| 834160 | - | - | - | 459277646 |
| 834161 | - | - | - | 459278460 |
| 834196 | - | - | - | 459278740 |
| 834197 | - | - | - | 459278456 |
| 834374 | - | - | - | 459277103 |
| 834375 | - | - | - | 459277916 |
| 835418 | - | - | - | 459277475 |
| 835419 | - | - | - | 459278290 |
| 835563 | - | - | - | 459328201 |
| 835773 | - | - | - | 459636785 |
| 835774 | - | - | - | 459636828 |
| 835775 | - | - | - | 459636907 |
| 835776 | - | - | - | 459636991 |
| 835817 | - | - | - | 459636909 |
| 835818 | - | - | - | 459636738 |
| 836049 | - | - | - | 461477656 |
| 836050 | - | - | - | 461477664 |
| 836163 | - | - | - | 461483243 |
| 836407 | - | - | - | 461593900 |
| 836439 | - | - | - | 461650707 |
| 836440 | - | - | - | 461650696 |
| 836824 | - | - | - | 461650746 |
| 836941 | - | - | - | 461663123 |
| 836942 | - | - | - | 461663096 |
| 837081 | - | - | - | 461823403 |
| 837082 | - | - | - | 461823418 |
| 837396 | - | - | - | 462764937 |
| 837397 | - | - | - | 462764921 |
| 837398 | - | - | - | 462764928 |
| 837893 | - | - | - | 463821130 |
| 838377 | - | - | - | 464113151 |
| 838762 | - | - | - | 464868654 |
| 838763 | - | - | - | 464868809 |
| 839053 | - | - | - | 469398763 |
| 839102 | - | - | - | 469128523 |
| 839303 | Triptolide | - | - | 469691020 |
| 839697 | - | - | - | 470142021 |
| 839698 | - | - | - | 470142005 |
| 839699 | - | - | - | 470141998 |
| 839865 | - | - | - | 470142042 |
| 839866 | - | - | - | 470142011 |